- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07154836
- Original Trial
Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria (Call 4 Life)
August 26, 2025 updated by: Lundi-Anne Omam Ngo Bibaa, University of Cambridge
This study evaluates the feasibility and preliminary impact of Call for Life, an mHealth platform aimed at increasing childhood vaccination coverage among internally displaced persons in Borno State, Nigeria.
The platform uses an interactive voice response (IVR) system to deliver automated vaccination reminders, follow up on reported side effects, and provide health messages in English and local languages.
A mixed-methods design is used to assess feasibility, interaction rates, and early effects on vaccine uptake.
Findings will inform policymakers and humanitarian actors on the potential of mobile technology to strengthen immunization delivery in conflict-affected, resource-limited settings.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
366
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Borno State
-
Jere, Borno State, Nigeria
- El Miskin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
• Caregivers (male/female) of children from 0-23 months of age or pregnant women in third trimester
- Caregivers above the age of 18 years of age
- Caregivers who consent to participate in the study.
- Resident in the IDP camp for at least one year
Exclusion Criteria:
• Pregnant women in third trimester in first pregnancy (primigravida)
- Caregivers that are temporary residents of the IDP camps (IDPs on transit or visitors)
- Caregivers without the mental capacity to comprehend the questions asked.
- Inability to use or interact with a mobile phone ( e.g. those with hearing defects or poor vision)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Call4life
Care givers will be reminded using telephone calls to go vaccine their children
|
Regular telephone reminders and health information will be sent to help mothers or caregivers of children 0-23 months to remind them to go vaccine their children
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of zero-dose children aged 0-23 months vaccinated and registered in an immunization registry at the health facility
Time Frame: 6 months
|
Number of zero-dose children aged 0-23 months vaccinated and registered in an immunization registry at the health facility.
The immunization registry which will be used by the health facility to follow up with parents for the vaccination schedules of the children
|
6 months
|
|
Number of care givers to children aged 0-23 months who receive reminder calls from the call for life platform and take their children to the health facility for immunization
Time Frame: 6 months
|
Number of care givers to children aged 0-23 months who receive reminder calls from the call for life platform and take their children to the health facility for immunization and registration into an immunization registry
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 24, 2025
Primary Completion (Estimated)
November 24, 2025
Study Completion (Estimated)
December 30, 2025
Study Registration Dates
First Submitted
August 15, 2025
First Submitted That Met QC Criteria
August 26, 2025
First Posted (Estimated)
September 4, 2025
Study Record Updates
Last Update Posted (Estimated)
September 4, 2025
Last Update Submitted That Met QC Criteria
August 26, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Call-4-Life
- Not application (Other Identifier: Cambridge Africa)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
IDP will be shared with researchers involved in the study.
IPD Sharing Time Frame
January 2025 to December 2025
IPD Sharing Access Criteria
Only researchers involved in the study will have access to IPD
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Access to Immunization
-
Pacific Institute for Research and EvaluationUniversity of California, San Diego; University of New MexicoCompleted
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR)Not yet recruitingAccess to Primary CareCanada
-
University of British ColumbiaVancouver Foundation; Inner-City Women's Initiatives SocietyCompletedSafety | Access to Health Care | Outreach Intervention | Gender-Based Violence | Access to Social ServicesCanada
-
Syracuse VA Medical CenterVA Office of Research and Development; Michael E. DeBakey VA Medical CenterCompletedPsychological Distress | Access to CareUnited States
-
Iowa Adaptive Technologies, Inc.National Institute of Nursing Research (NINR)CompletedProblems With Access to Health Care
-
National Institutes of Health Clinical Center (CC)CompletedEase Of Access To Covid VaccineUnited States
-
Al-Azhar UniversityCompleted
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Ontario Ministry of Health and...Completed
-
B. Braun Melsungen AGCompletedIntravenous Access According to Instructions For UseGermany
-
Physeon GmbHRegulatory Clinical Research Institute (RCRI)TerminatedDifficult-to-access Veins for Intravenous CannulationUnited States
Clinical Trials on Telephone calls
-
US Department of Veterans AffairsCompletedSpinal Cord InjuryUnited States
-
Duke UniversityNational Institutes of Health (NIH)CompletedSmoking CessationUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoHealth Resources and Services Administration (HRSA)RecruitingSafety Plan | Caregiver Participation | Emergency Department PresentationUnited States
-
Dana-Farber Cancer InstituteHarvard Pilgrim Health CareCompleted
-
National Taipei University of Nursing and Health...Yuan's General HospitalCompleted
-
Monash UniversityNovartis PharmaceuticalsTerminatedCerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)Australia
-
Duke-NUS Graduate Medical SchoolChangi General Hospital; Agency for Integrated Care, SingaporeNot yet recruitingFrail Older Adults | Geriatric Syndromes | Frail Elderly PatientsSingapore
-
VA Office of Research and DevelopmentCompletedMultimorbidity | Cognitive ImpairmentsUnited States
-
German Research FoundationUnknownAttention Deficit and Disruptive Behavior Disorders | Oppositional Defiant Disorder | Attention Deficit Hyperactivity DisordersGermany
-
University of British ColumbiaCompletedMajor Depressive Disorder (MDD)Canada